Toledo, Spain

Sergio-Alvar Alonso-de-Diego


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Sergio Alvar Alonso de Diego**

Introduction

Sergio Alvar Alonso de Diego, an inventive mind based in Toledo, Spain, has made significant strides in the field of pharmaceuticals with his innovative research. His work primarily focuses on developing novel compounds that have therapeutic potential, particularly in the treatment of Alzheimer's disease.

Latest Patents

One of Sergio's key inventions is encapsulated in his patent for "Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease." This groundbreaking patent details unique substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-dione derivatives. The compounds described in this patent are valuable as gamma secretase modulators, providing new avenues for treatment options. The invention also includes processes for preparing these novel compounds, pharmaceutical compositions incorporating them as an active ingredient, and their application as medicaments.

Career Highlights

Sergio's professional journey includes notable stints at reputable organizations where his research prowess flourished. He has worked with Janssen Pharmaceuticals, Inc., where he contributed to the development of innovative pharmaceutical solutions. Additionally, his time at Cellzome Limited allowed him to further his expertise in biochemical research and drug discovery.

Collaborations

Throughout his career, Sergio has collaborated with esteemed professionals in the industry, including Frederik Jan Rita Rombouts and Andrés Avelino Trabanco-Suarez. These partnerships have facilitated a dynamic exchange of ideas and advancements in their respective fields.

Conclusion

In summary, Sergio Alvar Alonso de Diego stands out as a promising inventor whose contributions have the potential to significantly impact the treatment of Alzheimer's disease and other medical conditions. His dedication to innovation and collaboration underscores the importance of research in developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…